Two‐year outcomes following naloxone administration by police officers or emergency medical services personnel

AuthorDaniel O'Donnell,Spencer G. Lawson,Bradley R. Ray,Evan M. Lowder,Emily Sightes
Date01 August 2020
Published date01 August 2020
DOIhttp://doi.org/10.1111/1745-9133.12509
Received:  January   Revised:  June  Accepted:  June 
DOI: ./- .
SPECIAL ISSUE ARTICLE
CUTTING-EDGE RESEARCH IN POLICE POLICY AND PRACTICE
Two-year outcomes following naloxone
administration by police officers or emergency
medical services personnel
Evan M. Lowder1Spencer G. Lawson2Daniel O’Donnell3
Emily Sightes4Bradley R. Ray4
George Mason University
Michigan State University
Indiana University School of Medicine,
Indianapolis Emergency Medical Services
Wayne State University
Correspondence
EvanM. Lowder, Department of Crimi-
nology,Law and Society,George Mason
University, University Drive, F,
Fairfa x, VA .
Email:elowder@gmu.edu
Research Summary: We conducted a retrospective,
quasi-experimental study of a police naloxone program
to examine individual outcomes following nonfatal over-
dose where either police (n=) or emergency medical
services (n=,) provided a first response and admin-
istered naloxone. Individuals who received a police
response were more likely to be arrested immediately
following initial dispatch and had more instances of
repeat nonfatal overdose two years following dispatch;
there were no differences in rearrestor death rates. Find-
ings suggest police naloxone programs may increase
short-term incarceration risk, but we found little evi-
dence overall of long-term adverse effects.
Policy Implications: Naloxone is a tool to reduce
fatal opioid-involved overdose. Its provision alone does
not constitute a comprehensive agency response to the
opioid epidemic. Findings support the need for stan-
dardized policies and procedures to guide emergency
responses to nonfatal overdose events and ensure con-
sistency across agencies.
KEYWORDS
naloxone, nonfatal overdose, opioid epidemic, police
Criminology & Public Policy. ;:–. ©  American Society of Criminology 1019wileyonlinelibrary.com/journal/capp
1020 LOWDER  .
The overdose epidemic in the United States is now characterizedby a growing number of synthetic
opioid-involved deaths (Scholl, Seth, Kariisa, Wilson, & Baldwin, ). Specifically,the synthetic
opioid fentanyl, which is  times stronger than morphine, has been implicated in the majority
of opioid overdose deaths (Jalal et al., ; Lowder, Ray, Huynh, Ballew, & Watson, ). From
 to , the age-adjusted rate of synthetic opioid overdose deaths increased from . to .
per , U.S. residents (Hedegaard, Miniño, & Warner, ). Since , more people have
died of synthetic opioids than any other class of opioids (Ahmad, Escobedo, Spencer, Warner, &
Sutton, ).
In the face of the growing lethality of opioid use in the United States, naloxone has emerged as
a primary harm reduction tool to reduce fatal overdose events. Naloxone is a medication and opi-
oid antagonist that works to counteract the effects of opioids, particularly respiratory depression,
and can be administered via numerous routes (intravenously, subcutaneously, intramuscularly,
or intranasally). As a harm reduction strategy, naloxone is not intended to reduce drug use or
provide treatment for drug use, but is intended to mitigate the more serious consequence of illicit
opioid use as part of a broader public health strategy (Beletsky, Rich, & Walley, ; Hawk, Vaca,
&DOnofrio,; Kolodny et al., ; Nelson, Juurlink, & Perrone, ). Naloxone is a life-
saving medication (Chamberlain & Klein, ; He, Jiang, & Li, ), and efforts are underway
nationwide to increase the availability of naloxone beyond medical professionals. For example,
as of , nearly  community-based organizations reported providing naloxonekits to layper-
sons (Wheeler, Jones, Gilbert, & Davidson, ). Naloxone is now distributed to laypersons in
emergency departments (Dwyer et al., ) and local pharmacies (Morton et al., ), and there
is growing interest and support for the distribution of naloxone in jail settings (Davidson,Wagner,
Toka r, & Scho la r, ).
However, in many cases, a one-time naloxone administration by a lay responder may not
be sufficient to revive an individual who is overdosing, necessitating an emergency response.
Indeed, recent trends suggest multiple naloxone administrations in a single overdose encounter
are increasing (Faul et al., ). As a result, in addition to lay responders and medical person-
nel, many jurisdictions are equipping other first responders with naloxone to respond directly to
overdose incidents (Davis, Ruiz, Glynn, Picariello, & Walley, ). These efforts have targeted
police officers specifically, because they are likely to encounter individuals involved in an opi-
oid overdose (Wagner, Bovet, Haynes, Joshua, & Davidson, ) and can often respond to such
encounters more rapidly than emergency medical services, particularly in rural areas(Davis, Carr,
Southwell, & Beletsky, ; Fisher, O’Donnell, Ray, & Rusyniak, ). As of , more than
, law enforcement agencies across  states distributed naloxone as part of their emergency
response practices (Lurigio, Andrus, & Scott, ), representing approximately %–% of law
enforcement agencies nationwide (Banks, Hendrix, Hickman, & Kyckelhahn, ).
At least some preliminary study results show these efforts are promising. For example, one
prior study found that expanded access to naloxone among law enforcement was associated with
a reduction in opioid overdose deaths (Rando, Broering, Olson, Marco, & Evans, ). Another
study examining the effects of police officer naloxone training found that the majority of individ-
uals revived from an overdose via a police officer were not arrested, were cooperative, and volun-
tarily agreed to visit the hospital after revival (Fisher et al., ). Beyond contributing to positive
individual-level outcomes, expanded access to naloxone among police mayhelp to improve public
perception of the police and, accordingly, increase bystanders’ willingness to call  at the scene
of an overdose (Davis et al., ). Indeed, equipping police officers with naloxone in an attempt
to prevent overdose deaths has led to improved community relations between the lay public,
police officers, and other public health/community agencies (Beletsky et al., ). Although the

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT